Another study has linked Zofran to birth defects.

baby suffering from Zofran birth defect
Numerous studies have linked the use of Zofran during pregnancy with birth defects. A Zofran lawsuit, filed in the United States District Court Of The Eastern District Of Louisiana under claim number 2:15-cv-04399-SM-DEK, has noted that there have been many studies performed in which researchers believe the data showed that there is an increased risk of birth defects in children whose mothers took the anti-nausea medication Zofran.

The Studies

There have been several studies noted in almost all of the lawsuits filed against the manufacturers of Zofran, GlaxoSmithKline, including the Danielson Report, the Andersen Study, the Pasternak Study, and one of the most recent, a study performed by BioMed Research International.

The researchers for BioMed Research International reviewed birth records from 96,968 births. They determined which mothers were prescribed Zofran during their pregnancy and compared the birth records of children exposed to the drug with those whose mothers did not take the drug. They noted that children born to mothers who took Zofran during the first trimester had an increased risk of being born stillborn, that there was a 20% increased risk of a major birth defect, and that, specifically, there was an increased risk of being born with kidney defects.

Zofran Birth Defects

Zofran is an anti-emetic drug that has been on the market since the early 90’s. The drug was approved by the U.S. Food and Drug Administration, but not as a treatment for morning sickness, a condition commonly diagnosed in expectant mothers. The FDA indicated that the drug was safe to be prescribed to men and women experiencing nausea and vomiting after anesthesia, chemotherapy, and radiation.

GSK advertised the drug as a safe and effective treatment for pregnant women and their unborn children despite the fact that the FDA had not approved the drug for this use. The drug was prescribed to women all over the country. Soon, the company allegedly began to receive reports indicating that children had been born with severe birth defects after their mother had taken the drug.

Over the last two years, hundreds of lawsuits have been filed against GlaxoSmithKline. Each one alleges that the drug caused a birth defect in an unborn child. Birth defects include kidney defects, atrial septal defect, ventricular septal defect, transposition of the greater vessels, clubfoot, respiratory distress syndrome, cleft lip, and cleft palate. In each case, parents claim that their child’s quality of life is diminished because of their birth defect.

About Laurence Banville

Attorney Contributor:

Laurence P. Banville, Esq. is the managing partner of Banville Law. He is a regular contributor on several topics including negligent security cases, child sexual abuse and Dram Shop and liquor liability cases.

This article was fact checked prior to publishing by this author to ensure compliance with our rigorous editorial standards. We will only use authoritative sources. Our values compel us to provide only trustworthy information. If you find an error, please contact us.

View All Posts